PROPANC BIOPHARMA, INC.
Balance Sheet
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $8.2M | $7.7M | $8.8M | $8.4M | $9.7M | $18.0K | $21.5K | $25.4K |
| Property, Plant & Equipment | $4.2K | $4.4K | $2.4K | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $14.3M | $15.1M | $18.0M | $19.6M | $22.5M | $78.5K | $63.6K | $72.4K |
| Liabilities | ||||||||
| Accounts Payable | $973.7K | $957.5K | $1.1M | $1.2M | $1.1M | $1.2M | $1.2M | $1.2M |
| Total Current Liabilities | $3.5M | $3.6M | $3.6M | $5.6M | $4.3M | $4.2M | $4.1M | $3.8M |
| Long-Term Debt | $55.0K | $55.0K | $107.0K | $537.9K | $438.6K | $409.8K | $381.8K | $399.3K |
| Total Liabilities | $3.5M | $3.7M | $3.6M | $5.7M | $4.4M | $4.2M | $4.2M | $3.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-140.8M | $-134.5M | $-130.5M | $-125.6M | $-121.6M | $-67.5M | $-67.1M | $-66.7M |
| Total Stockholders' Equity | $9.8M | $10.5M | $14.4M | $13.9M | $18.1M | $-4.2M | $-4.1M | $-3.8M |